Secretory expression of human protein in the yeast Pichia pastoris by controlled fermentor culture

Recent Patents on Biotechnology

Volumn 4, Issue 2, 2010, Pages 153-166

  Murasugi, Akira ^a  

^a MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Bile salt stimulated lipase; Expanded bed adsorption; Fermentor culture; Growth hormone; Insulin; Midkine; Pichia pastoris; Pleiotrophin; Serum albumin; Therapeutic protein

Indexed keywords

CELLS; CYTOLOGY; FERMENTED MILK; GENETIC ENGINEERING; INSULIN; POLYSACCHARIDES; RECOMBINANT PROTEINS; SALTS; YEAST;

BILE SALTS; BILE-SALT STIMULATED LIPASE; EXPANDED BED ADSORPTION; FERMENTOR CULTURE; FERMENTORS; GROWTH HORMONES; MIDKINE; PICHIA PASTORIS; PLEIOTROPHIN; SERUM ALBUMIN; THERAPEUTIC PROTEIN;

BODY FLUIDS;

ALBUMIN; ALCOHOL OXIDASE; ALCOHOL OXIDASE 1; BILE SALT; COMPLEMENTARY DNA; GLYCAN; GLYCEROL; HUMAN GROWTH HORMONE; HUMAN INSULIN; INSULIN; MATING HORMONE ALPHA FACTOR; MIDKINE; PLEIOTROPHIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DISEASE; BURN; CELL GROWTH; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; EXPRESSION VECTOR; FERMENTATION MEDIUM; FERMENTATION OPTIMIZATION; FERMENTATION TECHNIQUE; GENE DUPLICATION; GENE NUMBER; GLYCOSYLATION; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HEMORRHAGIC SHOCK; HORMONE RELEASE; HUMAN; HYPOALBUMINEMIA; KIDNEY DISEASE; LIVER CIRRHOSIS; LIVER DISEASE; NEPHROSIS; NEUROPATHY; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UNSPECIFIED SIDE EFFECT;

PICHIA; PICHIA PASTORIS;

EID: 77954040786     PISSN: 18722083     EISSN: None     Source Type: Journal    
DOI: 10.2174/187220810791110679     Document Type: Article

References (112)

1. Xie T, Liu Q, Xie F, Liu H, Zhang Y. Secretory expressin of insulin precursor in Pichia pastoris and simple procedure for producing recombinant human insulin. Prep Biochem Biotechnol 2008; 38: 308-17.
2. Sreekrishna, K., Tschopp, J.F., Thill, G.P., Brierley, R.A., Barr, K.A. Expression of human serum albumin in Pichia pastoris. US5707828 (1998).
3. Kobayashi K, Kuwae S, Ohya T, Ohda T, Ohyama M, Ohi H, et al. High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J Biosci Bioeng 2000; 89: 55-61.
4. Cregg JM. Expression in the methylotrophic yeast Pichia pastoris. Gene expression systems. In: Fernandez JM, Hoeffler JP, Eds. Academic Press: USA 1999; 157-91.
5. Higgins DR, Cregg JM. Introduction to Pichia pastoris. Methods in molecular biology. Pichia protocols. In: Higgins DR, Cregg JM, Eds. Humana Press: USA 1998; 1-15.
6. nd ed. In: Cregg JM, Ed. Humana Press: USA 2007;1-10.
7. Cereghino GPL, Cereghino JL, Ilgen C, Cregg JM. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 2002; 13: 329-32.
8. Li P, Anumanthan A, Gao X-G, Ilangovan K, Nejat Düzgüne VVS, Renugopalakrishnan V. Expression of recombinant proteins in Pichia pastoris. Appl Biochem Biotechnol 2007; 142: 105-24.
9. Murasugi A. Optimized productions of recombinant human proteins in fermentor cultures of the yeast, Pichia pastoris. Curr Topics Biotechnol 2008; 4: 101-8.
10. Itakura K, Hirose T, Crea R, Riggs AD, Heyneker HL, Bolivar F, et al. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 1977; 198: 1056-63.
11. Goeddel DV, Heyneker HL, Hozumi T, Arentzen R, Itakura K, Yansura DG, et al. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 1979; 281: 544-8.
12. Itakura, K., Riggs, A.D. Recombinant cloning vehicle microbial polypeptide expression. US4704362 (1987).
13. Birch JR, Onakunle Y. Biopharmaceutical proteins: opportunities and challenges. In: Methods in molecular biology. Therapeutic proteins: methods and protocols. In: Smales CM, James DC, Eds. Humana Press: USA 2005; 308: 1-16.
14. Sumi A, Okuyama K, Kobayashi K, Ohtani W, Ohmura T, Yokoyama K. Purification of recombinant human serum albumin- efficient purification using STREAMLINE. Bioseparation 1999; 8: 195-200.
15. Murasugi A, Asami Y, Mera-Kikuchi Y. Production of recom- binant human bile salt-stimulated lipase in Pichia pastoris. Protein Expr Purif 2001; 23: 282-8.
16. Murasugi A, Tohma-Aiba Y. Production of native recombinant human midkine in the yeast, Pichia pastoris. Protein Expr Purif 2003; 27: 244-52.
17. Murasugi A, Kido I, Kumai H, Asami Y. Efficient production of recombinant human pleiotrophin in yeast, Pichia pastoris. Biosci Biotechnol Biochem 2003; 67: 2288-90.
18. nd World Conference on Magic Bullets. Nürnberg, Germany (2008).
19. Tanaka S, Ko K, Kino K, Tsuchiya K, Yamashita A, Murasugi A, et al. Complete amino acid sequence of an immunomodulatory protein, Ling Zhi-8 (LZ-8). An immuno-modulator from a fungus Ganoderma lucidum, having similarity to immunoglobulin variable regions. J Biol Chem 1989; 264: 16372-7.
20. Murasugi A, Tanaka S, Komiyama N, Iwata N, Kino K, Tsunoo H, et al. Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein, Ling Zhi-8 (LZ-8) from a fungus, Ganoderma lucidum. J Biol Chem 1991; 266, 2486-93.
21. Vervecken W, Kaigorodov V, Callewaert N, Geysens S, De Vusser K, Contreras R. In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris. Appl Environ Microbiol 2004; 70: 2639-46.
22. Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 2006; 313:1441-43.
23. Wegner, E.H. Biochemical conversions by yeast fermentation at high cell densities. US4617274 (1986).
24. Sreekrishna, K., Fuke, M., Potenz, R.H. Yeast production of human tumor necrosis factor. US5002876 (1991).
25. Brierley, R.A., Davis, G.R., Holtz, G.C. Production of insulin-like growth factor-1 in methylotrophic yeast cells. US5324639 (1994).
26. Higgins DR, Cregg JM, Eds. Methods in molecular biology. Pichia protocols. Humana Press: USA 1998; 103.
27. nd ed. Humana Press: USA 2007; 389.
28. de Bruin EC, Duitman EH, de Boer AL, Veenhuis M, Bos IGA, Hack CE. Pharmaceutical proteins from methylotrophic yeasts. Methods in molecular biology. Therapeutic proteins: methods and protocols. In: Smales CM, James DC, Eds. Humana Press: USA 2005; 308: 65-76.
29. Tolner B, Smith L, Begent RHJ, Chester KA. Production of recombinant protein in Pichia pastoris by fermentation. Nat Protocols 2006; 1: 1006-21.
30. nd ed. In: Cregg JM, Ed. Humana Press: USA 2007; 389: 11-25.
31. Cregg, J.M., Barringer, K.J. Pichia transformation. US4929555 (1990)
32. Inan M, Meagher MM. Non-repressing carbon source for alcohol oxidase (AOX1) promoter of Pichia pastoris. J Biosci Bioeng 2001; 92: 585-9.
33. Hang H, Ye X, Guo M, Chu J, Zhuang Y, Zhang M, et al. A simple fermentation strategy for high-level production of recombinant phytase by Pichia pastoris using glucose as the growth substrate. Enzyme Microbial Technol 2009; 44: 185-8.
34. Buckholz, R.G. Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same. US5268273 (1993).
35. Novick P, Ferro S, Schekman R. Order of events in the yeast secretory pathway. Cell 1981; 25: 461-9.
36. Caplan S, Green R, Rocco J, Kurjan J. Glycosylation and structure of the yeast MF 1 -factor precursor is important for efficient transport through the secretory pathway. J Bacteriol 1991; 173: 627-35.
37. Brierley RA. Secretion of recombinant human insulin-like growth factor 1 (IGF-1). Methods in molecular biology. Pichia protocols. In: Higgins DR, Cregg JM, Eds. Humana Press: USA 1998; 103: 149-77.
38. Fuller RS, Sterne RE, Thorner J. Enzymes required for yeast prohormone processing. Annu Rev Physiol 1988; 50: 345-62.
39. Murasugi A, Tohma-Aiba Y. Characterization of partially truncated human midkine expressed in Pichia pastoris. Biosci Biotechnol Biochem 2002; 66: 1295-300.
40. Trimble RB, Lubowski C, Hauser CR III, Stack R, McNaughton L, Gemmill TR, et al. Characterization of N- and O-linked glycosylation of recombinant human bile salt-stimulated lipase secreted by Pichia pastoris. Glycobiology 2004; 14: 265-74.
41. Mattiasson B, Nandakmar MP. Physicochemical basis of expanded-bed adsorption for protein purification. Handbook of bioseparations. Separation science and technology. In: Ahuja S, Ed. Academic Press: USA 2000; 2: 417-30.
42. Shiloach J, Kennedy RM. Expanded-bed adsorption process for protein capture. Handbook of Bioseparations: Separation Science and Technology. In: Ahuja S, Ed. Academic Press: USA 2000; 2: 431-53.
43. Davis J, Hofmann MJ. Access valve devices, their use in separation apparatus and corresponding methods. US5902485 (1999).
44. Noda, M., Sumi, A., Ohmura, T., Yokoyama, K. Process for purifying recombinant human serum albumin. US5962649 (1999).
45. Noda, M., Sumi, A., Ohmura, T., Yokoyama, K. Process for purifying recombinant human serum albumin. US20036617133 (2003).
46. Barr KA, Hopkins SA, Sreekrishna K. Protocol for efficient secretion of HSA developed from Pichia pastoris. Pharm Eng 1992; 12: 48-51.
47. Prevatt, W.D., Sreekrishna, K. Expression of human serum albumin in Pichia pastoris. US5330901 (1994).
48. Okabayashi K, Nakagawa Y, Hayasuke N, Ohi H, Miura M, Ishida Y, et al. Secretory expression of the human serum albumin gene in the yeast, Saccharomyces cerevisiae. J Biochem 1991; 110: 103-10.
49. Ohmura, T., Sumi, A., Ohtani, W., Fuluhata, N., Takeshima, K., Kamide, K., Noda, M., Kondo, M., Ishikawa, S., Oohara, K., Yokoyama, K. Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same. US5440018 (1995).
50. Ohi H, Miura M, Hiramatsu R, Ohmura T. The positive and negative cis-acting elements for methanol regulation in the Pichia pastoris AOX2 gene. Mol Gen Genet 1994; 243: 489-99.
51. Ohi, H., Miura, M., Uno, S., Chuganji, M., Hiramatsu, R., Ohmura, T. Mutant AOX2 promoter, vector carrying same, transformant, and production of heterlogous protein. US5683893 (1997).
52. Kobayashi, K., Tomomitsu, K., Kuwae, S., Ohya, T., Ohda, Y., Ohmura, T. Method for producing protein. US20006068995 (2000).
53. Ohya T, Ohyama M, Kobayashi K. Optimization of human serum albumin production in methylotrophic yeast Pichia pastoris by repeated fed-batch fermentation. Biotechnol Bioeng 2005; 90: 876-87.
54. Fuluhata, N., Sumi, A., Ohmura, T. Method for highly purifying human serum albumin. US5656729 (1997).
55. Kobayashi, K., Tomomitsu, K., Kuwae, S., Ohya, T., Ohda, T. Process for producing human serum albumin. US5631145 (1997).
56. Ohi H, Okazaki N, Uno S, Miura M, Hiramatsu R. Chromosomal DNA patterns and gene stability of Pichia pastoris. Yeast 1998; 14: 895-903.
57. Ohmura, T., Sumi, A., Ohtani, W. Furuhata, N., Takeshima, K., Kamide, K., Noda, M., Kondo, M., Ishikawa, S., Oohara, K., Yokoyama, K., Fujiwara, N. Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same. US5986062 (1999).
58. Bell GI, Swain WF, Pictet R, Cordell B, Goodman HM, Rutter WJ. Nucleotide sequence of a cDNA clone encoding human preproinsulin. Nature 1979; 282: 525-7.
59. Brange J, Langkjær L. Insulin structure and stability. Pharma- ceutical Biotechnology: Stability and characterization of protein and peptide drugs: case histories. In: Wang YJ, Pearlman R, Eds. Plenum Press: USA 1993; 5: 315-50.
60. Goeddel DV, Kleid DG, Bolivar F, Heynecker HL, Yansura DG, Crea R, et al. Expression in Escherichaia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci USA 1979; 76: 106-10.
61. Thim L, Hansen MT, Norris K, Hoegh I, Boel E, Forstrom J, et al. Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA 1986; 83: 6766-70.
62. Kjeldsen T, Pettersson AF, Hach M. Secretory expression and characterization of insulin in Pichia pastoris. Biotechol Appl Biochem 1999; 29: 79-86.
63. Mansur M, Cabello C, Hernández L, Pais J, Varas L, Valdés J, et al. Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris. Biotechnol Lett 2005; 27: 339-45.
64. Wang Y, Liang Z-H, Zhang Y-S, Yao S-Y, Xu Y-G, Tang Y-H, et al. Human insulin from a precursor over-expressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product. Biotechnol Bioeng 2001; 73: 74-9.
65. Markussen J, Damgaard U, Diers I, Fiil N, Hansen MT, Larsen P, Norris F, Norris K, Schou O, Snel L, Thim L, Voigt HO. Diabetologia 1986; 29: 568A-569A
66. Xie T, Liu Q, Xie F, Liu H, Zhang Y. Secretory expression of insulin precursor in Pichia pastoris and simple procedure for producing recombinant human insulin. Prep Biochem Biotechnol 2008; 38: 308-17.
67. Kjeldsen, T.B., Ludvigsen, S., Kaarsholm, N.C. Method for making insulin precursors and insulin precursor analogs. US20067087408 (2006).
68. Kjeldsen, T.B., Markussen, J. Processes for making acylated insulin. US20060264606 (2006).
69. Annibali, N. Expression of a human insulin precursor in P. pastoris. US20067091032 (2006).
70. DeNoto FM, Moore DD, Goodman HM. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res 1981; 9: 3719-30.
71. Pearlman R, Bewley TA. Stability and characterization of human growth hormone. Pharmaceutical Biotechnology: Stability and characterization of protein and peptide drugs: Case histories. In: Wang YJ, Pearlman R, Eds. Plenum Press: USA 1993; 5: 1-58.
72. Martial JA, Hallewell RA, Baxter JD, Goodman HM. Human growth hormone: complementary DNA cloning and expression in bacteria. Science 1979; 205: 602-7.
73. Treviño LLE, Salvadó JMV, Saldaña HAB, Olazarán MG. Biosynthesis and secretion of recombinant human growth hormone in Pichia pastoris. Biotechnol Lett 2000; 22: 109-14.
74. Olazarán, M.G., Saldaña, H.B., Salvadó, J.M.V. Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone. US20026342375 (2002).
75. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumori- genesis. J Biochem 2002; 132: 359-71.
76. Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T. A new family of heparin-binding factors: strong conservation of midkine (MK) sequence between the human and the mouse. Biochem Biophys Res Commun 1991; 176: 792-7.
77. Iwasaki W, Nagata K, Hatanaka H, Inui T, Kimura T, Muramatsu T, et al. Solution structure of midkine, a new heparin-binding growth factor. EMBO J 1997; 16: 6936-46.
78. Unoki K, Ohba N, Arimura H, Muramatsu H, Muramatsu T. Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest Ophthalmol Vis Sci 1994; 35: 4063-8.
79. Yoshida Y, Ikematsu S, Moritoyo T, M Goto, Tsutsui J, Sakuma S, et al. Intra-ventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neural death following transient forebrain ischemia in gerbils. Brain Res 2001; 894: 46-55.
80. Uchida, M., Ikematsu, S., Yokoyama, M. Yamashita, A., Kumai, H., Oda, M., Kato, N., Sakuma, S., Muramatsu, T. Treatment of peptic ulcers using midkine (MK) proteins. US20006083907 (2000)
81. Kikuchi, M., Ikematsu, S., Oda, M., Sakuma, S., Muramastu, T. Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells. US20056939669 (2005)
82. Ikematsu, S., Yoshida, Y., Kadomatsu, K. Oda, M., Sakuma, S., Ashida, K.-Y., Kino, K., Muramatsu, T. Therapeutic agents for apoptosis-related diseases. US20050079151 (2005).
83. Murasugi, A., Asami, Y., Kido, I., Kumai, H. High level secretory expression system of intact MK family protein. US20056867037 (2005).
84. Clare JJ, Romanos MA, Rayment FB, Rowedder JE, Smith MA, Payne MM, et al. Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 1991; 105: 205-12.
85. Asami Y, Nagano H, Ikematsu S, Murasugi A. An approach to the removal of yeast specific O-linked oligo-mannoses from human midkine expressed in Pichia pastoris using site-specific mutagenesis. J Biochem 2000; 128: 823-6.
86. Murasugi A, Tohma-Aiba Y, Asami Y. Production of recombinant human midkine in yeast, Pichia pastoris. J Biosci Bioeng 2000; 90: 395-9.
87. Murasugi A, Aiba Y. Comparison of three signals for secretory expression of recombinant human midkine in Pichia pastoris. Biosci Biotechnol Biochem 2001; 65: 2291-3.
88. Milner PG, Shah D, Veile R, Donis-Keller H, Kumar BV. Cloning, nucleotide sequence, and chromosome localization of the human pleiotrophin gene. Biochemistry 1992; 31: 12023-8.
89. Hamosh M. Enzymes in human milk: their role in nutrient digestion, gastrointestinal function, and nutrient delivery to the newborn infant. Textbook of gastroenterology and nutrition in infancy. In: Lebenthal E, Ed. Raven Press: New York USA 1989; 121-34.
90. Hernell O, Bläckberg L, Chen Q, Sternby B, Nilsson Å. Does the bile salt-stimulated lipase of human milk have a role in the use of the milk long-chain polyunsaturated fatty acids? J Pediatr Gastroenterol Nutr 1993; 16: 426-31.
91. Baba T, Downs D, Jackson KW, Tang J, Wang CS. Structure of human milk bile salt activated lipase. Biochemistry 1991; 30: 500-10.
92. Reue K, Zambaux J, Wong H, Lee G, Leete TH, Ronk M, et al. cDNA cloning of carboxylester lipase from human pancreas reveals a unique proline-rich repeat unit. J Lipid Res 1991; 32: 267-76.
93. Hui DY, Kissel JA. Sequence identity between human pancreatic cholesterol esterase and bile salt-stimulated milk lipase. FEBS Lett 1990; 276: 131-4.
94. Kyger EM, Wiegand RC, Lange LG. Cloning of the bovine pancreatic cholesterol esterase/lysophospholipase. Biochem Biophys Res Commun 1989; 164: 1302-9.
95. Fontaine RN, Carter CP, Hui DY. Structure of the rat pancreatic cholesterol esterase gene. Biochemistry 1991; 30: 7008-14.
96. Hansson L, Bläckberg L, Edlund M, Lundberg L, Strömqvist M, Hernell O. Recombinant human milk bile salt-stimulated lipase. Catalytic activity is retained in the absence of glycosylation and the unique proline-rich repeats. J Biol Chem 1993; 268: 26692-8.
97. Murasugi, A., Asami, Y. Expression of recombinant bile salt activated lipase in high yield. JP199507111891 (1995).
98. Sahasrabudhe AV, Solapure SM, Khurana R, Suryanarayan V, Ravishankar S, deSousa SM, et al. Production of recombinant human bile salt-stimulated lipase and its variant in Pichia pastoris. Protein Expr Purif 1998; 14: 425-33.
99. Das, G. DNA molecules for expression of bile salt-stimulated lipase. US20030040040 (2003).
100. Adkins Y, Lönnerdal B. Proteins and peptides. Bioprecesses and biotechnology for functional foods and neutraceuticals. In: Neeser J-R, German JB, Eds. Marcel Dekker: USA 2004; 167-96.
101. Landberg E, Huang Y, Strömqvist M, Mechref Y, Hansson L, Lundblad A, et al. Changes in glycosylation on human bile salt- stimulated lipase during lactation. Arch Biochem Biophys 2000; 377: 246-54.
102. Mechref Y, Chen P, Novotny MV. Structural characterization of the N-linked oligosaccharides in bile salt-stimulated lipase originated from human breast milk. Glycobiology 1999; 9: 227-34.
103. Que AH, Mechref Y, Huang Y, Taraszka JA, Clemmer DE, Novotny MV. Coupling capillary electrochromatography with electrospray Fourier transform mass spectrometry for charac- terizing complex oligosaccharide pools. Anal Chem 2003; 75: 1684-90.
104. Choi B-K, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, et al. Use of combinatorial genetic libraries to humanize N- linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci USA 2003; 100: 5022-7.
105. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, et al. Production of complex human glycoproteins in yeast. Science 2003; 301: 1244-6.
106. Bobrowicz P, Davidson RC, Li H, Potgieter TI, Nett JH, Stephen Hamilton R, et al. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Glycobiology 2004; 14: 757-66.
107. Contreras, R., Callewaert, N.L.M., Geysens, S.C.J. Protein glycosylation modification in Pichia pastoris. US20046803225 (2004).
108. Wildt, S., Miele, R.G., Nett, J.H., Davidson, R.C. Method to engineer mammanlian-type carbohydrate structures. US20050170452 (2005).
109. Contreras, R., Callewaert, N.L.M., Geysens, S.C.J., Kaigorodov, V., Wouter, V. Protein glycosylation modification in methylotrophic yeast. US20077252933 (2007).
110. Bobrowicz, P., Stadheim, T.A., Wildt, S. Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins. US20077259007 (2007).
111. Gerngross, T.U. Methods for producing modified glycoproteins. US20087326681 (2008)
112. Contreras, R., Callewaert, N.L.M., Geysens, S.C.J., Kaigorodov, V., Wouter, V. Protein glycosylation modification in methylo- trophic yeast. US20080009037 (2008).